Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Partners Investment
AddedFeb 13, 2024
UpdatedJun 28, 2026
Partners Investment

Partners Investment

Operating

Long-term investment firm specializing in mid-late stage ventures, enhancing portfolio companies.

Location
Seoul, Seoul, KR
Founded
2017
Firm
Compare
Portfolio
Employees

Investments

Cytonus Therapeutics
Cytonus Therapeutics

Total Raised

$18.9M

Rounds

11

Series A$11.7MNovember 2023
Series UnknownFebruary 2023
Seed$1.8MJuly 2022
Harbinger Health
Harbinger Health

Total Raised

$190M

Rounds

2

Series B$140MSeptember 2023
AltPep
AltPep

Total Raised

$76M

Rounds

2

Series B$52.9MJune 2023
Adcentrx Therapeutics
Adcentrx Therapeutics

Total Raised

$101M

Rounds

2

Series A$51MApril 2023
Ring Therapeutics
Ring Therapeutics

Total Raised

$253.5M

Rounds

3

Series C$86.5MMarch 2023
Series B$117MJuly 2021
Sonde Health
Sonde Health

Total Raised

$41.3M

Rounds

4

Series B$19.3MDecember 2022
Senda Biosciences
Senda Biosciences

Total Raised

$309M

Rounds

3

Series C$123MAugust 2022
Series B$98MJune 2021
AmazeVR
AmazeVR

Total Raised

$50.8M

Rounds

6

Series B$5.5MJanuary 2022
Series B$9.5MApril 2021
Series A$2.5MJanuary 2020
Allo
Allo

Total Raised

$2.1B

Rounds

6

Seed$5MDecember 2021
AffaMed Therapeutics
AffaMed Therapeutics

Total Raised

$170M

Rounds

1

Series B$170MMarch 2021
Phantom AI
Phantom AI

Total Raised

$85.7M

Rounds

4

Series A$22MApril 2020
Vedanta Biosciences
Vedanta Biosciences

Total Raised

$433.1M

Rounds

15

Series C$16.6MSeptember 2019
Series C$18.5MMay 2019